A Trial of SHR-1703 in Healthy Adults

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
SHR-1703 is a monoclonal antibody under development for severe asthma. This study is the first study in Healthy subjects. The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose SHR-1703 administered subcutaneously in Chinese healthy subjects.
Epistemonikos ID: 76da4c818acc60378def8df84825003bb9538f2f
First added on: May 07, 2024